ACADIA Pharmaceuticals, Inc. (ACAD)
28.91
-0.20
(-0.69%)
USD |
NASDAQ |
Aug 31, 16:00
28.91
0.00 (0.00%)
Pre-Market: 20:00
ACADIA Pharmaceuticals Net Income (TTM) : 380.48M for June 30, 2026
Net Income (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Net Income (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 380.48M |
| March 31, 2026 | 375.65M |
| December 31, 2025 | 391.00M |
| September 30, 2025 | 261.17M |
| June 30, 2025 | 222.16M |
| March 31, 2025 | 228.88M |
| December 31, 2024 | 226.45M |
| September 30, 2024 | 128.51M |
| June 30, 2024 | 30.56M |
| March 31, 2024 | -1.71M |
| December 31, 2023 | -61.29M |
| September 30, 2023 | -148.81M |
| June 30, 2023 | -110.82M |
| March 31, 2023 | -145.94M |
| December 31, 2022 | -215.98M |
| September 30, 2022 | -217.34M |
| June 30, 2022 | -204.62M |
| March 31, 2022 | -214.48M |
| December 31, 2021 | -167.87M |
| September 30, 2021 | -191.54M |
| June 30, 2021 | -261.74M |
| March 31, 2021 | -260.01M |
| December 31, 2020 | -281.58M |
| September 30, 2020 | -267.86M |
| June 30, 2020 | -225.18M |
| Date | Value |
|---|---|
| March 31, 2020 | -237.98M |
| December 31, 2019 | -235.26M |
| September 30, 2019 | -247.72M |
| June 30, 2019 | -267.88M |
| March 31, 2019 | -276.20M |
| December 31, 2018 | -245.19M |
| September 30, 2018 | -248.57M |
| June 30, 2018 | -251.68M |
| March 31, 2018 | -255.86M |
| December 31, 2017 | -289.40M |
| September 30, 2017 | -299.23M |
| June 30, 2017 | -305.59M |
| March 31, 2017 | -309.47M |
| December 31, 2016 | -271.39M |
| September 30, 2016 | -238.48M |
| June 30, 2016 | -205.77M |
| March 31, 2016 | -173.83M |
| December 31, 2015 | -164.44M |
| September 30, 2015 | -147.02M |
| June 30, 2015 | -132.90M |
| March 31, 2015 | -115.02M |
| December 31, 2014 | -92.48M |
| September 30, 2014 | -76.16M |
| June 30, 2014 | -62.07M |
| March 31, 2014 | -49.65M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (TTM) Benchmarks
| Incyte Corp. | 1.612B |
| Agios Pharmaceuticals, Inc. | -411.29M |
| Biogen, Inc. | 834.60M |
| Insmed, Inc. | -875.31M |
| Vertex Pharmaceuticals, Inc. | 4.405B |